Xiao-Jun Lin

3.5k total citations · 2 hit papers
24 papers, 2.6k citations indexed

About

Xiao-Jun Lin is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Xiao-Jun Lin has authored 24 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 8 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Xiao-Jun Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Hepatitis B Virus Studies (4 papers). Xiao-Jun Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Hepatitis B Virus Studies (4 papers). Xiao-Jun Lin collaborates with scholars based in China, Hong Kong and Taiwan. Xiao-Jun Lin's co-authors include Rong Guo, Min-Shan Chen, Ya-Qi Zhang, Hui-Hong Liang, Wan Yee Lau, Jin-Qing Li, Yun Zheng, Yaojun Zhang, Zhenwei Peng and Ming Shi and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Surgery.

In The Last Decade

Xiao-Jun Lin

23 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma

2006 1.0k citations Min-Shan Chen, Jin-Qing Li et al. Annals of Surgery profile →
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial

2012 369 citations Zhenwei Peng, Yaojun Zhang et al. Journal of Clinical Oncology profile →

Peers

Xiao-Jun Lin

HEPAT

EPIDE

SURGE

ONCOL

PRM

Ya-Qi Zhang China

Jin-Qing Li China

Hui-Hong Liang China

Yukihiro Koike Japan

Lluís Bianchi Spain

Masato Abei Japan

Chung‐Mau Lo Hong Kong

Sophie Michalak France

Maurizio Tommasini Italy

Tadao Unuma Japan

Ya-Qi Zhang China

Xiao-Jun Lin

2.2k ×1.0

HEPAT

1.3k ×1.0

EPIDE

905 ×0.9

SURGE

411 ×0.9

ONCOL

352 ×0.8

PRM

Citations per year, relative to Xiao-Jun Lin Xiao-Jun Lin (= 1×) peers Ya-Qi Zhang

Countries citing papers authored by Xiao-Jun Lin

Since Specialization

Citations

This map shows the geographic impact of Xiao-Jun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Jun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Jun Lin more than expected).

Fields of papers citing papers by Xiao-Jun Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Jun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Jun Lin. The network helps show where Xiao-Jun Lin may publish in the future.

Co-authorship network of co-authors of Xiao-Jun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Jun Lin. A scholar is included among the top collaborators of Xiao-Jun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Jun Lin. Xiao-Jun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Xiao-Jun, et al.. (2025). Epstein-Barr virus mRNA vaccine synergizes with NK cells to enhance nasopharyngeal carcinoma eradication in humanized mice. PubMed. 33(2). 200986–200986. 1 indexed citations

Lin, Xiao-Jun, et al.. (2025). Innovative Sargassum fusiforme polysaccharide composites for cryoprotection of large yellow croaker (Larimichthys crocea) fillets during frozen storage. Food Chemistry. 489. 144961–144961. 1 indexed citations

Lin, Xiao-Jun, et al.. (2024). Trimetallic-doped carbon nitride achieves chondroitin sulfate degradation via a free radical degradation strategy. Carbohydrate Polymers. 346. 122616–122616. 1 indexed citations

Lin, Xiao-Jun, Gen Li, Shoubing Wang, et al.. (2024). High-performance electromagnetic wave absorption in FeS₂/SnS₂@multi-walled carbon nanotube composites with honeycomb-shaped structure. Dalton Transactions. 53(45). 18175–18182.

Zheng, Jie, Xiao-Jun Lin, Xu Han, et al.. (2024). Enzyme-mediated green synthesis of glycosaminoglycans and catalytic process intensification. Biotechnology Advances. 74. 108394–108394. 7 indexed citations

Yang, Yongzheng, et al.. (2023). (3+1)-dimensional Pearcey–Gaussian wave packet with arbitrary velocity driven by flying focus. Optics Letters. 49(2). 290–290. 1 indexed citations

Zou, Ru-Hai, Wei Wei, Jing-Xian Shen, et al.. (2018). Comparison of Stable and Unstable Ethiodized Oil Emulsions for Transarterial Chemoembolization of Hepatocellular Carcinoma: Results of a Single-Center Double-Blind Prospective Randomized Controlled Trial. Journal of Vascular and Interventional Radiology. 29(8). 1068–1077.e2. 15 indexed citations

Chen, Jian Lin, Xiao-Jun Lin, Qian Zhou, et al.. (2016). Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection. Chinese Journal of Cancer. 35(1). 28–28. 28 indexed citations

Lin, Xiao-Jun, et al.. (2015). Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC). BMC Cancer. 15(1). 707–707. 35 indexed citations

10.

Xu, Li, Zhenwei Peng, Min-Shan Chen, et al.. (2015). Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Journal of Hepatology. 63(1). 122–130. 104 indexed citations

11.

Zhang, Mei-Yin, Shu-Hong Li, Guoliang Huang, et al.. (2015). Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis. BMC Cancer. 15(1). 64–64. 35 indexed citations

12.

Peng, Zhenwei, Yaojun Zhang, Min-Shan Chen, et al.. (2012). Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial. Journal of Clinical Oncology. 31(4). 426–432. 369 indexed citations breakdown →

13.

Wu, Qiu-Liang, et al.. (2012). Clinicopathological Characteristics and Outcome of Primary Sarcomatoid Carcinoma and Carcinosarcoma of the Liver. Journal of Gastrointestinal Surgery. 16(9). 1715–1726. 51 indexed citations

14.

Peng, Zhenwei, Xiao-Jun Lin, Yaojun Zhang, et al.. (2012). Radiofrequency Ablation versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas 2 cm or Smaller: A Retrospective Comparative Study. Radiology. 262(3). 1022–1033. 169 indexed citations

15.

Shi, Ming, Ligong Lu, Rong Guo, et al.. (2012). Roles Played by Chemolipiodolization and Embolization in Chemoembolization for Hepatocellular Carcinoma: Single-Blind, Randomized Trial. JNCI Journal of the National Cancer Institute. 105(1). 59–68. 60 indexed citations

16.

Chen, Yan-Feng, Su Liu, Jun Wang, et al.. (2012). Antitumour activity of Lycium chinensis polysaccharides in liver cancer rats. International Journal of Biological Macromolecules. 51(3). 314–318. 29 indexed citations

17.

Liu, Su, et al.. (2012). Effect of Tea Polyphenol on Oxidative Injury in S180 Cells Induced Hepatocarcinoma Mice. International Journal of Molecular Sciences. 13(5). 5571–5583. 5 indexed citations

18.

Peng, Zhenwei, Yaojun Zhang, Hui-Hong Liang, et al.. (2011). Recurrent Hepatocellular Carcinoma Treated with Sequential Transcatheter Arterial Chemoembolization and RF Ablation versus RF Ablation Alone: A Prospective Randomized Trial. Radiology. 262(2). 689–700. 166 indexed citations

19.

Lao, Xiang‐Ming, Dongying Chen, Ya-Qi Zhang, et al.. (2007). Primary Carcinosarcoma of the Liver: Clinicopathologic Features of 5 Cases and a Review of the Literature. The American Journal of Surgical Pathology. 31(6). 817–826. 58 indexed citations

20.

Shi, Ming, Rong Guo, Xiao-Jun Lin, et al.. (2006). Partial Hepatectomy With Wide Versus Narrow Resection Margin for Solitary Hepatocellular Carcinoma. Annals of Surgery. 245(1). 36–43. 378 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact